EPIRUS Biopharmaceuticals, Inc.
https://epirusbiopharma.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From EPIRUS Biopharmaceuticals, Inc.
Another Infliximab Biosimilar On Horizon In India?
More competition appears to be in the wings for Remicade in India after the Russian firm Biocad’s biosimilar infliximab was endorsed in India by an expert panel, though there’s little clarity on launch specifics, at least for now.
Appointments: Piramal Pharma, Oxeia, Artios Eyevensys and Bone Therapeutics
This week's roundup includes a new CEO for Oxeia, in addition to various other high-level appointments by Piramal Pharma Solutions, Bone Therapeutics, Kiadis and biOasis. Artios Pharma also welcomes AstraZeneca's former senior director bioscience, oncology to its team.
Orphan Biosimilars: Developers See Big Prospects In Small Markets; Soliris Is One Target
Using lessons learned from the first wave of biosimilar approvals – and citing high prices in the US – some developers are starting to 'think small' with biosimilars for rare disease markets. Alexion’s Soliris is a case in point.
Orphan Biosimilars: Developers See Big Prospects In Small Markets; Soliris Is One Target
Using lessons learned from the first wave of biosimilar approvals – and citing high prices in the US – some developers are starting to 'think small' with biosimilars for rare disease markets. Alexion’s Soliris is a case in point.
Company Information
- Industry
- Pharmaceuticals
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule
- Other Names / Subsidiaries
-
- Bioceros Holding B.V.
- CombinatoRx, Inc.
- EB Sub, Inc.
- Epirus Biopharmaceuticals Ltd.
- Epirus Biopharmaceuticals (Switzerland) GmbH
- Epirus Brasil Tecnologia Ltda
- Epirus Biopharmaceuticals (Netherlands) B.V.
- Fourteen22, Inc.
- Neuromed Pharmaceuticals Inc.
- Zalicus Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice